Screening for Drugs of Abuse. I: Opiates,Amphetamines and Cocaine

Editorial. Screening for drugs of abuse. Lancet 1987; i: 365–6.

Greenwood J. Lothian's Community Drug Problem Service—A Five Year Review 1988–1993. Edinburgh: Community Drug Problem Service, Lothian Health Board, 1994.

Gossop M Green L Phillips G Bradley B. What happens to opiate addicts immediately after treatment: A prospective follow up study. BMJ 1993; 294: 1377–80.

Griffin S Peters A Reid M. Drug misusers in Lothian: Changes in injecting habits 1988–90. BMJ 1993; 306: 693.

Cooper JR . Methadone treatment and acquired immunodeficiency syndrome. JAMA 1989; 262: 1664–8.

Smith BL . A brief introduction to drug abuse for clinical chemists. In: Hill PG Moore RA , eds. Drugs of Abuse Screening: The Requirements and Provision of a Laboratory Service. London: Association of Clinical Biochemists, 1988: 1–16.

Mikkelson SL Ash KO . Adulterants causing negatives in illicit drug testing. Clin Chem 1988; 34: 2333–6.

Warner A. Interference of common household chemicals in immunoassay methods for drugs of abuse. Clin Chem 1989; 35: 649–51.

Schwarzhoff R Cody JT . The effects of adulterating agents on FPIA analyses of urine for drugs of abuse. J Anal Toxicol 1993; 17: 14–17.

Lafolie P Beck O Blennow G Boreus L Borg S Elwin C-E Importance of creatinine analysis of urine when screening for abused drugs. Clin Chem 1991; 37: 1927–31.

Wolff K Shanab MA Sanderson MJ Kay AWM . Screening for drugs of abuse: Effect of heat-treating urine for safe handling of samples. Clin Chem 1990; 36: 908–10.

Simpson D Greenwood J Jarvie DR Moore FML . Experience of a laboratory service for drug screening in urine. Scott Med J 1993; 38: 20–6.

Minty PSB . Interpretation of Drug Assays. In: Hill PG Moore RA , eds. Drugs of Abuse Screening: The Requirements and Provision of a Laboratory Service. London: Association of Clinical Biochemists, 1988: 36–55.

De Crease R Magura A Lifshitz M Tilson J. Drug Testing in the Workplace. Chicago: American Society of Clinical Pathologists, 1989: 1–11.

Sunshine I. Preliminary testing for drugs of abuse. Clin Chem 1989; 34: 331–4.

American Association for Clinical Chemistry. Critical issues in urinalysis of abused substances: Report of the Substance-Abuse Testing Committee. Clin Chem 1989; 34: 605–32.

Bosomworth MP . Drugs of abuse in urine: Some pitfalls in testing. Br J Biomed Sci 1993; 50: 150–5.

De Crease R Magura A Lifshitz M Tilson J. Drug Testing in the Workplace. Chicago: American Association of Clinical Pathologists, 1989: 84–96.

Morphine. In: Moffat AC Jackson JV Moss MS Widdop B , eds. Clark's Isolation and Identification of Drugs, 2nd Edition. London: The Pharmaceutical Press, 1986: 790.

Tompsett SL . Extraction procedures in chemical toxicology. Analyst 1968; 93: 740–8.

Mule SJ Casella GA . Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening. J Anal Toxicol 1988; 12: 102–7.

Jaffe JH Martin WR . Opioid analgesics and antagonists. In: Gilman A Goodman Rall TW Nies AS Taylor P , eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, Eighth Edition. New York: Macmillan, 1990: 485–521.

Hayes LW Krasselt WG Mueggler PA . Concentration of morphine and codeine in serum and urine after ingestion of poppy seeds. Clin Chem 1987; 33: 806–8.

Zebelman AM Troyer BL Randall GL Batjer JD . Detection of morphine and codeine following consumption of poppy seeds. J Anal Toxicol 1987; 11: 131–2.

Elsohly MN Elsohly MA Stanford DF . Poppy seed ingestion and opiates urinalysis: A closer look. J Anal Toxicol 1990; 14: 308–10.

Selovka CM . Poppy seed ingestion as a contributing factor to opiate-positive urinalysis results: The Pacific perspective. J Forensic Sci 1991; 36: 685–96.

Stanski DR Greenblatt DJ Lowenstein E. Kinetics of intravenous and intramuscular morphine. Clin Pharmacol Ther 1978; 24: 52–9.

Sarve J Dahlstrom B Palzow L Rane A. Pharmacokinetics of morphine in cancer patients. Clin Pharmacol Ther 1981; 30: 629–35.

Sawe J. High dose morphine and methadone in cancer patients: Clinical pharmacokinetic considerations of oral treatment. Clin Pharmacokinet 1986; 11: 87–106.

Yeh SY . Urinary excretion of morphine and its metabolites in morphine-dependent subjects. J Pharmacol Exp Ther 1975; 192: 201–10.

Boerner U Abbott S Roe RL . The metabolism of morphine and heroin in man. Drug Metab Rev 1975; 4: 39–73.

Yeh SY Gorodetzky CW Krebs HA . Isolation and identification of morphine-3,6-diglucuronide, morphine-3-etheral sulphate, normorphine and normorphine-6-glucuronide and morphine metabolites in humans. J Pharm Sci 1977; 66: 1288–93.

Sevenson JO Rane A Sawe J Sjoquist F. Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high performance liquid chromatography. J Chromatogr B Biomed Appl 1982; 230: 427–32.

Osborne RJ Joel SP Slevin ML . The pharmacokinetics of morphine and morphine glucuronides in normal volunteers after four routes of administration. Br J Cancer 1986; 23: 227–8.

Sevenson JO . Determination of morphine, morphine-6-glucuronide and normorphine in plasma and urine with high performance liquid chromatography and electrochemical detection. J Chromatogr 1986; 375: 174–8.

Shimomura K Kamata O Ueki S Ida S Oguri K Yoshimura H Analgesic effects of morphine glucuronides. Tohuku J Exp Med 1971; 105: 45–52.

Osborne R Joel S Trew D Slevins M. Analgesic activity of morphine-6-glucuronide. Lancet 1988; i: 828.

Wennig R. Practical Compendium for Health Professionals: Drugs of Abuse Currently Used in Europe. Luxembourg: Commission of the European Communities (Directorate General Employment, Industrial Relations and Social Affairs, Health and Safety Directorate), 1992: 30–4.

Inturrisi CE Max MB Foley KM Schultz M Shin S-U Houde RW . The pharmacokinetics of heroin in patients with chronic pain. N Engl J Med 1984; 310: 1213–17.

Derks HJGM Van Twillert K Zomer G. Determination of 6-acetylmorphine in urine as a specific marker for heroin abuse by high performance liquid chromatography with fluorescence detection. Anal Chim Acta 1985; 197: 13–20.

Mule SJ Casella GA . Rendering the ‘poppy-seed defence’ defenseless: Identification of 6-monoacetylmorphine in urine by gas chromatography/mass spectroscopy. Clin Chem 1988; 34: 1427–30.

Cone EJ Welch P Mitchell JM Paul BD . Forensic drug testing for opiates: I. Detection of 6-acetylmorphine in urine as an indicator of recent heroin exposure; drug and assay considerations and detection times. J Anal Toxicol 1990; 15: 1–7.

Cone EJ Welch P Paul BD Mitchell JM . Forensic drug testing for opiates: III. Urinary excretion rates of morphine and codeine following codeine administration. J Anal Toxicol 1991; 15: 161–6.

Alder TK Fujimoto JM Way EL Baker EM . The metabolic fate of codeine in man. J Pharm Exp Ther 1955; 114: 251–62.

Posey BL Kimble SN . High performance liquid chromatographic study of codeine, norcodeine and morphine as indicators of codeine ingestion. J Anal Toxicol 1984; 25: 68–74.

Rowell FJ Seymour RA Lawlins MD . Pharmacokinetics of intravenous and oral dihydrocodeine and its acid metabolites. Eur J Clin Pharmacol 1983; 25: 419–24.

Chen ZR Siebert DM Somoggi AA Bochner F. Determination of pholcodine in biological fluids by high performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Appl 1988; 424: 170–6.

Widdop B. Methods for drug abuse screening. In: Hill PG Moore RA , eds. Drugs of Abuse Screening: The Requirements and Provision of a Laboratory Service. London: Association of Clinical Biochemists, 1988: 17–35.

Davidow B Li Petri N Quame B. A thin-layer chromatographic screening procedure for detecting drug abuse. Am J Clin Pathol 1968; 50: 714–19.

Moffat AC . Thin-layer chromatography. In: Moffat AC Jackson JV Moss MS Widdop B , eds. Clark's Isolation and Identification of Drugs, 2nd Edition. London: The Pharmaceutical Press, 1986: 160–77.

Stead AH Gill R Wright T Gibbs JP Moffat AC . Standardised thin-layer chromatographic systems for the identification of drugs and poisons. Analyst 1982; 107: 1106–68.

Slim S Barnes P Allen L. Screening for morphine/heroin abuse with Toxi-Lab Systems [Letter]. Ann Clin Biochem 1987; 24: 641–2.

Nadkarni S Faye S Hay A. Experience with the use of Toxi-Lab TLC system in screening for morphine/heroin abuse. Ann Clin Biochem 1987; 24: 211–2.

Simpson D Jarvie DR Heyworth R. An evaluation of six methods for the detection of drugs of abuse in urine. Ann Clin Biochem 1989; 26: 172–81.

Wilson JF . Performance of techniques used to detect drugs of abuse in urine. Ther Drug Monit 1993; 15: 175.

Wolff K Sanderson MJ Hay AWM Barnes I. An evaluation of the measurement of drugs of abuse by commercial and in-house horizontal thin layer chromatography. Ann Clin Biochem 1993; 30: 163–8.

Mercia Diagnostics Ltd. Alternative developing solutions—part III. In: Toxi-Lab Newsletter, Vol 2, No. 2. Guildford, Surrey: Mercia Diagnostics Ltd, 1986: 1.

Paul BD Mell LD Jr Mitchell JM Irving J Novak AJ . Simultaneous identification and quantitation of codeine and morphine in urine by capillary gas chromatography and mass spectroscopy. J Anal Toxicol 1985; 9: 222–6.

Cone EJ Darwin WD . Rapid assay of cocaine, opiates and metabolites by GC-MS. J Chromatogr B Biomed Appl 1992; 580: 43–6.

Moore RA Baldwin D McQuay HJ Bullingham RES . HPLC of morphine with electrochemical detection analysis in human plasma. Ann Clin Biochem 1985; 21: 125–30.

Kim C Kats T. Rapid and sensitive analysis of morphine in serum by reverse-phase high performance liquid chromatography with electrochemical detection. J Anal Toxicol 1984; 8: 135–7.

Zoer J Virgili P Henry JA . High performance liquid chromatographic assay for morphine with electrochemical detection using an unmodified silica column with a non-aqueous ionic eluent. J Chromatogr 1987; 382: 189–97.

Moore FML Simpson D. Detection of opiates in urine: A cost-effective low risk immunoassay procedure. Med Lab Sci 1989; 46: 309–12.

Cone EJ Dickerson S Paul BD Mitchell JM . Forensic drug testing for opiates. V. Urine testing for heroin, morphine, and codeine with commercial opiate immunoassays. J Anal Toxicol 1993; 17: 156–64.

Rambohul E Ruprah M. Experience with a haemagglutination inhibition test for morphine detection in urine. Ann Clin Biochem 1985; 22: 211–12.

Armbruster DA Krolak JM . Screening for drugs of abuse with the Roche ONTRAK assays. J Anal Toxicol 1992; 16: 172–5.

Wilson JF Williams J Walker G Toseland PA Smith BL Richens A Performance of techniques used to detect drugs of abuse in urine: Study based on external quality assessment. Clin Chem 1991; 37: 442–7.

Henry JA . Ecstasy and the dance of death. BMJ 1992; 305: 5–6.

Henry JA Jeffreys KJ Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”). Lancet 1992; 340: 384–7.

Beckett AH Rowland M. Urinary excretion kinetics of amphetamine in man. J Pharm Pharmacol 1965; 17: 628–39.

Frings CF Queen C Foster LB . Improved colorimetric method for assay of amphetamines in urine. Clin Chem 1971; 17: 1016–9.

Matthew RW Browne HC Weber JB . Rapid method for the determination of numerous pharmaceutically important amines. Assoc Off Anal Chem 1972; 55: 789–93.

Rutter ER . Automated method for screening urine for amphetamine and some related primary amines. Clin Chem 1972; 18: 616–20.

Mosnaim AD Inwang EE Sugerman JH De Martini WJ Sabelli HC . Ultraviolet spectrophotometric determination of 2-phenylethylamine in biological samples and its possible correlation with depression. Biol Psychiat 1973; 6: 235–57.

Hayes TS . Automated fluorometric determination of amphetamines in urine. Clin Chem 1973; 19: 390–4.

Mule SJ Bastos ML Jukotsky D Saffer E. Routine identification of drugs of abuse in human urine. J Chromatogr 1971; 63: 289–301.

Ramsey JD Campbell DB . An ultra rapid method for the extraction of drugs from biological fluids. J Chromatogr 1971; 63: 303–8.

Caldwell R Challenger H. A capillary column gas-chromatographic method for the identification of drugs of abuse in urine samples. Ann Clin Biochem 1989; 26: 430–43.

Stoner RE Parker C. Single-pH extraction procedure for detecting drugs of abuse. Clin Chem 1974; 20: 309–11.

Meola J Vanko M. Use of charcoal to concentrate drugs from urine before drug analysis. Clin Chem 1974; 20: 184–7.

Kullberg MP Miller WL McGowan FJ Doctor BP . Studies in the single extraction of amphetamine and phenobarbital from urine using XAD-2 resin. Biochem Med 1973; 7: 323–35.

Lanz RK Elisenberg RB . Evaluation of the JET technique for extracting drugs from urine. Clin Chem 1978; 24: 821–4.

Breiter J Helger R Lang H. Evaluation of column extraction: A new procedure for the analysis of drugs in body fluids. Forensic Sci 1976; 7: 131–40.

Geldmacher V Mallinckrodt M. Investigations on the recovery of acidic and basic drugs in urine by column extraction. In: Heyndrickx A , ed. Human Toxicology. Ghent, Belgium: European Press, 1978: 83–9.

Blakesley J Wood D House C Spencer-Peet J. A simplified thin-layer chromatography system for the detection of commonly abused basic drugs. Ann Clin Biochem 1987; 24: 508–10.

Monforte J Bath RJ Sunshine I. Fluorometric determination of primary and secondary amines in blood and urine after thin-layer chromatography. Clin Chem 1972; 18: 1329–33.

Cartoni GP Lederer M Polidori F. Some chromatographic and electrophoretic data for amphetaminelike drugs. J Chromatogr 1972; 71: 370–5.

Reisch J Alfes H Kommert HJZ . Analysis of medicinal mixtures. XIV. Thin-layer chromatography of NBD (4-chloro-7-nitrobenzo-furan) of phenylethylamine compounds. Fresenius Z Anal Chem 1969; 247: 56–7.

Bastos ML Kananen GE Young RM Monforte JR Sunshine I. Detection of basic organic drugs and their metabolites in urine. Clin Chem 1970; 16: 931–40.

Wochinger F Yagud I. Seventeen amines—Thin layer chromatography. Off Racing Chem 1970; 24: 230–1.

Caldwell J Dring LG Williams RT . Biliary excretion of amphetamine and methylamphetamine in the rat. Biochem J 1972; 129: 25–9.

Viala A Cano JP Catalin J Angeletti A. Routine method for the toxicological investigation of amphetamine in urine. Bull Soc Pharm Marseille 1971; 20: 143–54.

Mule SJ . Routine identification of drugs of abuse in human urine. J Chromatogr 1971; 55: 255–66.

Klein B Sheehan J Grumberg B. Use of fluorescamine (“Fluram”) to detect amphetamine in urine by thin-layer chromatography. Clin Chem 1974; 20: 272–4.

O'Brien BA Bonichamp JM Jones DW . Differentiation of amphetamine and its major hallucinogenic derivatives using thin-layer chromatography. J Anal Toxicol 1982; 6: 143–7.

Beckett AH Tucker GT Moffat AC . Routine detection and identification in urine of stimulants and other drugs, some of which may be used to modify performance in sport. J Pharm Pharmacol 1967; 19: 273–94.

Well J Cimbura G Koves E. The use of the liquid phase Poly A-103 in toxicology. J Chromatogr 1973; 83: 225–7.

Wells CEJ . Collaborative study of the gas-liquid chromatographic method for stereochemical composition of amphetamine. Assoc Off Anal Chem 1972; 55: 146–8.

Noonan JS Murdock PW Ray RS . A method for detecting amphetamine using gas-chromatography of a halogenated derivative. J Pharmacol Exp Ther 1969; 168: 205–9.

Anggard E Gunne LM Nickasson F. Gas chromatographic determination of amphetamine in blood, tissue and urine. Scand J Clin Lab Invest 1970; 26: 137.

Bruce RB Maynard WR . Determination of amphetamine and related amines in blood by gas chromatography. Anal Chem 1969; 41: 977–9.

Terada M Yamamoto S Yoshida S Kuroiwa Y Yoshimura S. Rapid and highly sensitive method for determination of methamphetamine and amphetamine in urine by electron-capture gas chromatography. J Chromatogr 1982; 237: 285–92.

Kinberger B Holmen A Wahrgren P. Determination of underivatized CNS-stimulants and methadone in urinary extracts by glass capillary gas chromatography. J Chromatogr 1981; 207: 148–51.

Ehresmen DJ Price SM Laktua DJ . Screening biological samples for underivatized drugs using a splitless injection technique on fused silica capillary column gas chromatography. J Anal Toxicol 1985; 9: 55–62.

Cowan DA Woffendin G. Drug testing in human sports. Spectra 1988; 11: 4–9.

Thurman EM Pedersen MJ Stout RL Martin T. Distinguishing sympathomimetic amines from amphetamine and methamphetamine in urine by gas chromatography/mass spectrometry. J Anal Toxicol 1992; 16: 19–27.

Lim HK Sakashita CO Foltz RL . The application of chemical ionization to drug analysis. Spectra 1988; 11: 10–14.

Kinberger B. Sensitive method for the high-performance liquid chromatographic determination of amphetamine in urinary extracts. J Chromatogr 1981; 213: 166–9.

Slais K Nielan MW Brinkman UA Frei RW . Screening of amphetamines by gradient microbore liquid chromatography and pre-column technology. J Chromatogr 1987; 393: 57–68.

Ishikawa K Martinez JL McGangh JL . Simple determination of p-hydroxyamphetamine by high performance liquid chromatography with electrochemical detection. J Chromatogr 1984; 306: 394–7.

Shimosato K Tomita M Ijiri I. Urinary excretion of p-hydroxylated methamphetamine metabolites in man. Arch Toxicol 1986; 59: 135–40.

Smith RN . Immunoassays in forensic toxicology. In: Oliver J , Ed. Forensic Toxicology. London: Croom Helm, 1978: 34–47.

Cleeland R Christenson J Usategui-Gomez M Heveran J Davis R Grunberg E. Detection of drugs of abuse by radioimmunoassay: A summary of published data and some new information. Clin Chem 1976; 22: 712–25.

Kunsman GW Manno JE Cockerham KR Manno BR . Application of Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyethamphetamine (MDEA) in urine. J Anal Toxicol 1990; 14: 149–53.

Poklis A Hall KV Eddleton RA Fitzgerald RL Saady JJ Bogema SC . EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. I. Stereoselectivity and clinical evaluation. Forensic Sci Int 1993; 59: 49–62.

Poklis A Fitzgerald RL Hall KV Saady JJ . EMIT-d.a.u. monoclonal amphetamine methamphetamine assay. II Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA). Forensic Sci Int 1993; 59: 63–70.

Olsen KM Gulliksen M Christophersen AS . Metabolites of chlorpromazine and brompheniramine may cause false-positive urine amphetamine results with monoclonal EMIT d.a.u. immunoassay [Letter]. Clin Chem 1992; 38: 611–2.

Crone T Dawson CM Tickner TR . False-positive results from the Syva EMIT d.a.u. monoclonal amphetamine assay as a result of antipsychotic drug therapy [Letter]. Clin Chem 1993; 39: 549.

Dasgupta A Saldona S Kinnaman G Smith M Johansen K. Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: More specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay. Clin Chem 1993; 39: 104–8.

Caplan YH Levine B Goldberger B. Fluorescence polarization immunoassay evaluated for screening for amphetamine and methylamphetamine in urine. Clin Chem 1987; 33: 1200–2.

Syva Company. Syva EMIT Drug Abuse Urine Assays Cross-Reactivity List. San Jose, USA: Syva Company, 1991.

Baselt RC . Urine drug screening by immunoassay: Interpretation of results. In: Baselt RC , ed. Advances in Analytical Toxicology, Vol. 1. Foster City, CA: Biochemical Publications, 1984: 81–123.

Watson ID Tames FJ Borland W Smith B. Unequivocal epidemiology of substance abuse in cities in the UK. Ther Drug Monit 1993; 15: 175.

Resnick RB Kestenbaum RS Schwartz LK . Acute systemic effects of cocaine in man: A controlled study by intranasal and intravenous routes. Science 1977; 195: 696–8.

Van Dyke C Barash PG Jatlow P Byck R. Cocaine: Plasma concentrations after intranasal applications in man. Science 1976; 191: 859–61.

Wennig R. Practical Compendium for Health Professionals: Drugs of Abuse Currently Used in Europe. Luxembourg: Commission of the European Communities (Directorate General Employment, Industrial Relations and Social Affairs. Health and Safety Directorate), 1992: 22–5.

Baselt RC . Disposition of Toxic Drugs and Chemicals in Man, 2nd edn. Davis, CA: Biomedical Publications, 1982: 193–8.

Wilkinson P Van Dyke C Jatlow P Barash P Byck R. Intranasal and oral cocaine kinetics. Clin Pharmacol Ther 1980; 27: 386–94.

Javaid JI Fischman MW Schuster CR Dekirmenjian H Davis JM . Cocaine plasma concentration: Relation to physiological and subjective effects in humans. Science 1978; 202: 227–8.

Ambre J. The urinary excretion of cocaine and metabolites in humans: A kinetic analysis of published data. J Anal Toxicol 1985; 9: 241–5.

Fish F Wilson WDC . Excretion of cocaine and its metabolites in man. J Pharm Pharmacol 1969; 21 (suppl): 135S–138S.

Ambre J Fischman M Ruo TI . Urinary excretion of ecgonine methyl ester, a major metabolite of cocaine in humans. J Anal Toxicol 1984; 8: 23–5.

Stewart DJ Inaba T Lucassen M Kalow W. Cocaine metabolism: Cocaine and norcocaine hydrolysis by liver and serum enzymes. Clin Pharmacol Ther 1979; 25: 464–8.

Zhang JY Foltz RL . Cocaine metabolism in man: Identification of four previously unreported cocaine metabolites in human urine. J Anal Toxicol 1990; 14: 201–5.

Smith RM . Arylhydroxy metabolites of cocaine in the urine of cocaine users. J Anal Toxicol 1984; 8: 35–7.

Smith RM Poquette MA Smith PJ . Hydroxymethoxybenzoylmethylecgonines: New metabolites of cocaine from human urine. J Anal Toxicol 1984; 8: 29–34.

Smith RM . Ethyl ester of arylhydroxy- and arylhydroxymethoxycocaines in the urines of simultaneous cocaine and ethanol users. J Anal Toxicol 1984; 8: 38–42.

Lowry WT Lomonte JN Hatchett D Garriott JC . Identification of two novel cocaine metabolites in bile by gas chromatography and gas chromatography/mass spectrometry in a case of acute intravenous cocaine overdose. J Anal Toxicol 1979; 3: 91–5.

Osterloh J. Testing for drugs of abuse—pharmacokinetic considerations for cocaine in urine. Clin Pharmacokinet 1993; 24: 355–61.

Vitti TG Boni RL . Metabolism of cocaine. In: Barnett G Chiang CN , eds. Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs, A Research Monograph. California: Biomedical Publications, 1985: 427–40.

Lukaszewski T Jeffrey WK . Impurities and artifacts of illicit cocaine. J Forensic Sci 1980; 25: 499–507.

Garrett ER Seyda K. Prediction of stability in pharmaceutical preparations XX: Stability evaluation and bioanalysis of cocaine and benzoylecgonine by high performance liquid chromatography. J Pharm Sci 1983; 72: 258–71.

Das Gupta V. Stability of cocaine hydrochloride solutions at various pH values as determined by high-pressure liquid chromatography. Int J Pharm 1982; 10: 249–57.

Cody JT . Stability of benzoylecgonine in urine. In: Jones GR Singer PP , eds. Proceedings of the 24th International Meeting of the Association of Forensic Toxicologists 1987. Edmonton, Alberta: Alberta Society of Clinical and Forensic Toxicologists, 1988: 183–92.

Wallace JE Hamilton HE Schwertner H King DE McNay JL Blum K. Thin-layer chromatographic analysis of cocaine and benzoylecgonine in urine. J Chromatogr 1975; 114: 433–41.

Jacob P Elias-Baker BA Jones RT . Determination of cocaine in plasma by automated gas chromatography. J Chromatogr 1984; 306: 173–81.

Goenechea S Rucker G Neugebauer M Zerell U. Extraction, quantitative gas chromatographic determination and gas chromatographic/mass spectrometric detection of ecgonine for identification of cocaine and its metabolites in urine. Fresenius Z Anal Chem 1986; 323: 326–9.

Mule SJ Casella GA . Confirmation and quantitation of cocaine, benzoylecgonine, ecgonine methyl ester in human urine by GC/MS. J Anal Toxicol 1988; 12: 153–5.

Clarke DR Hajar TM . Detection and confirmation of cocaine use by chromatographic analysis for methylecgonine in urine. Clin Chem 1987; 33: 118–9.

Valentour JC Aggarwal V McGee MP Goza SW . Cocaine and benzoylecgonine determination in postmortem samples by gas chromatography. J Anal Toxicol 1978; 2: 134–7.

Graas JE Watson E. The GC/MS determination of benzoylecgonine in urine following an extractive alkylation technique. J Anal Toxicol 1978; 2: 80–2.

Joern WA . Routine detection of benzoylecgonine in urine at a sensitivity of 35 ng/mL by a combination of EMIT and gas chromatography/mass spectrometry. J Anal Toxicol 1987; 11: 110–12.

Rafla FK Epstein RL . Identification of cocaine and its metabolites in human urine in the presence of ethyl alcohol. J Anal Toxicol 1979; 3: 59–63.

United Nations (Division of Narcotic Drugs). Recommended Methods for Testing Cocaine. New York: United Nations (Division of Narcotic Drugs), 1986: 1–32.

Jacob P Elias-Baker BA Jones RT Benowitz NL . Determination of benzoylecgonine and cocaine in biological fluids by automated gas-chromatography. J Chromatogr 1987; 417: 277–86.

Jain NC Chinn DM Budd RD Sneath TS Leung WJ . Simultaneous determination of cocaine and benzoylecgonine in urine by gas chromatography with on-column alkylation. J Forensic Sci 1977; 22: 7–16.

Froldi R Gambaro V Mariani R Pisoni F Procaccianti P. Rapid quantitation of cocaine and benzoylecgonine in urine by “on-column” capillary gas chromatography after “Extralut” extraction. Farm Ed Pr 1984; 39: 417–23.

McCurdy HH . Quantitation of cocaine and benzoylecgonine after JETUBE extraction and derivatization. J Anal Toxicol 1980; 4: 82–5.

Jindal SP Vestergaard P. Quantitation of cocaine and its principal metabolite, benzoyl ecgonine, by GLC-mass spectrometry using stable isotope labelled analogues as internal standards. J Pharm Sci 1978; 67: 811–4.

Marsubara K Maseda C Fukui Y. Quantitation of cocaine, benzoylecgonine and ecgonine methyl ester by GC-CI-SIM after Extralut extraction. Forensic Sci Int 1984; 26: 181–92.

Spiehler VR Reed DW . Brain concentrations of cocaine and benzoylecgonine in fatal cases. J Forens Sci 1985; 4: 1003–11.

Chinn DM Crouch DJ Peat MA Finkle BS Jennison TA . Gas chromatography-chemical ionization mass spectrometry of cocaine and its metabolites in biological fluids. J Anal Toxicol 1980; 4: 37–42.

Isenschmid DS Levine BS Caplan YH . A method for the simultaneous determination of cocaine, benzoylecgonine and ecgonine methyl ester in blood and urine using GC/EIMS with derivatization to produce high mass molecular ions. J Anal Toxicol 1988; 12: 242–5.

Griesemer EC Liu Y Budd RD . The determination of cocaine and its major metabolite, benzoylecgonine, in post mortem fluids and tissues by computerised gas chromatography/mass spectrometry. J Forens Sci 1983; 28: 894–900.

Kogan MJ Verebey KG De Pace AC . Quantitative determination of benzoylecgonine and cocaine in human bio-fluids by gas-liquid chromatography. Anal Chem 1977; 49: 1965–9.

Barnett G Hawks R Resnick R. Cocaine pharmacokinetics in humans. J Ethnopharmac 1981; 3: 353–66.

Jindal SP Lutz T Vestergaard P. Mass spectrometric determination of cocaine and its biologically active metabolite, norcocaine in human urine. Biomed Mass Spectrom 1978; 5: 658–63.

Taylor RW Jain NC George MP . Simultaneous identification of cocaine and benzoylecgonine using solid phase extraction and gas chromatography/mass spectrometry. J Anal Toxicol 1987; 11: 233–4.

Aderjan RE Schmitt G Wu M Mayor C. Determination of cocaine and benzoylecgonine by derivatization with iodomethane-D, or PFPA/ HFIP in human blood and urine using GC/MS (El or PCL mode). J Anal Toxicol 1993; 17: 51–5.

Saferstein R Manura JJ Brettell TA De PK . Drug detection in urine by chemical ionization mass spectrometry. J Anal Toxicol 1978; 2: 245–9.

Thompson LK Yousefnejad D Kumor K Sherar M Cone EJ . Confirmation of cocaine in human saliva after intravenous use. J Anal Toxicol 1987; 11: 36–8.

Jeffcoat AR Cook CE Perez-Reyes M. Applications of liquid chromatography to pharmacological studies of psychoactive drugs. In: Barnett G Chiang CN , eds. Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs, a Research Monograph. California: Biomedical Publications, 1985: 441.

Selavka CM Krull IS Lurie IS . An improved method for the rapid screening of illicit cocaine preparation using high performance liquid chromatography with electrochemical detection. Forensic Sci Int 1986; 31: 103–17.

Schwartz RS David KO . Liquid chromatography of opium alkaloids, heroin, cocaine and related compounds using electrochemical detection. Anal Chem 1985; 57: 1362–6.

Svensson JO . Determination of benzoylecgonine in urine from drug abusers using ion pair high performance liquid chromatography. J Anal Toxicol 1986; 10: 122–4.

Khan M Gupta PK Cristie R Nangia A Winter H Lam FC Determination of pharmacokinetics in sheep by liquid chromatography. J Pharm Sci 1987; 76: 39–43.

Evans MA Morarity T. Analysis of cocaine and cocaine metabolites by high pressure liquid chromatography. J Anal Toxicol 1980; 4: 19–22.

Masoud AN Krupski DM . High performance liquid chromatographic analysis of cocaine in human plasma. J Anal Toxicol 1980; 4: 305–10.

Jatlow PI Van Dyke C Barash P Byck R. Measurement of benzoylecgonine and cocaine in urine. Separation of various cocaine metabolites using reversed phase high performance liquid chromatography. J Chromatogr 1978; 152: 115–21.

Poklis A. Evaluation of TDx cocaine metabolite assay. J Anal Toxicol 1987; 11: 228–30.

Hackett LP Dusci LJ Ilett KF . The analysis of several non-opiate narcotic analgesics and cocaine in serum using high performance liquid chromatography. J Anal Toxicol 1987; 11: 269–71.

Tebbett IR McCartney QW . A rapid method for the extraction of cocaine and benzoylecgonine from body fluids. Forensic Sci Int 1988; 39: 287–91.

Hamilton HE Wallace JE Shimek EL Jr Land P Harris SC Christenson JG . Cocaine and benzoylecgonine excretion in humans. J Forensic Sci 1977; 22: 697–707.

Cone EJ Menchen SL Paul BD Mell LD Mitchell J. Validity testing of commercial urine cocaine metabolite assays, I. Assay detection times, individual excretion patterns and kinetics after cocaine administration in humans. J Forensic Sci 1989; 34: 15–31.

Harris SC Hamilton HE Wallace JE . Incidence of cocaine metabolites in urine specimens from medical examiners’ cases. J Forensic Sci 1979; 24: 307–11.

Cone EJ Weddington WW. Jr Prolonged occurrence of cocaine in human saliva and urine after chronic use. J Anal Toxicol 1989; 13: 65–8.

Dawling S Ward N Essex EG Widdop B. Rapid measurement of basic drugs in blood applied to clinical and forensic toxicology. Ann Clin Biochem 1990; 27: 473–7.

Dawling S Essex EG Ward N Widdop B. Gas chromatographic measurement of cocaine in serum, plasma and whole blood. Ann Clin Biochem 1990; 27: 478–81.

Yee HY Nelson JD Papa VM . Measurement of benzoylecgonine in whole blood using the Abbott ADx analyzer. J Anal Toxicol 1993; 17: 84–6.

Diosi DT Harvey DC . Analysis of whole blood for drugs of abuse using EMIT d.a.u. reagents and a Monarch 1000 chemistry analyzer. J Anal Toxicol 1993; 17: 133–7.

Schramm W Smith RH Craig PA Kidwell DA . Drugs of abuse in saliva: A review. J Anal Toxicol 1992; 16: 1–9.

Caddy B. Saliva as a specimen for drug analysis. In: Baselt RC , ed. Advances in Analytical Toxicology, Volume I. California: Biomedical Publications, 1993: 198–254.

Harkey MR Henderson GL Zhou C. Simultaneous quantitation of cocaine and its major metabolites in human hair by gas chromatography/chemical ionization mass spectrometry. J Anal Toxicol 1991; 15: 260–5.

Baumgartner WA Hill VA Blahd WH . Hair analysis for drugs of abuse. J Forensic Sci 1989; 34: 1433–53.

Strang J Marsh A Desouza N. Hair analysis for drugs of abuse [Letter]. Lancet 1990; i: 740.

Goldberger BA Caplan YH Maguire T Cone EJ . Testing human hair for drugs of abuse. III. Identification of heroin and 6-acetylmorphine as indicators of heroin use. J Anal Toxicol 1991; 15: 226–31.

Nakahara Y Takahasi K Shimamine M Saitoh A. Hair analysis for drugs of abuse: IV. Determination of total morphine and confirmation of 6-acetylmorphine in monkeys and human hair by GC/MS. Arch Toxicol 1992; 66: 669–74.

Nakahara Y Takahashi K Shimamine M Takeda Y. Hair analysis for drugs of abuse: I. Determination of methamphetamine and amphetamine in hair by stable isotope dilution gas chromatography/mass spectrometry method. J Forensic Sci 1991; 36: 70–8.

Martinez F Poet TS Pillai R Erickson J Estrada AL Watson RR . Cocaine metabolite (benzoylecgonine) in hair and urine of drug users. J Anal Toxicol 1993; 17: 138–42.

Bermejo AM Ramos I Fernandez P Lopez-Rivadulla M Cruz A Chiarotti M Morphine detection by gas chromatography/mass spectrometry in human vitreous humor and comparison with radioimmunoassay. J Anal Toxicol 1992; 16: 372–4.

Wilson JF Williams J Walker G Toseland PA Smith BL Richens A Sensitivity and specificity of techniques used to detect drugs of abuse in urine. In: Sunshine I , ed. Recent Developments in Therapeutic Drug Monitoring and Clinical Toxicology. New York: Marcel Dekker, Inc., 1992: 527–35.

Wilson JF Smith BL Toseland PA Williams J Burnett D Hirst AD External quality assessment of techniques for the detection of drugs of abuse in urine. Ann Clin Biochem 1994; 31: 335–42.

Kaufmann RE . Drug assays in the office. J Pediat 1990; 116: 268–70.

Baselt RC . Disposition of Toxic Drugs and Chemicals in Man, 2nd edn. Davis, CA: Biomedical Publications, 1982: 488–90.

Baselt RC . Disposition of Toxic Drugs and Chemicals in Man, 2nd edn. Davis, CA: Biomedical Publications, 1982: 42–5.